These numbers represent some of the most impressive weight loss results in pharmaceutical history, and they required injection of precisely manufactured, rigorously tested medication
This is not a complete risk summary - patients should review Eden's full published safety information and discuss risks with a licensed healthcare provider before beginning any GLP-1 treatment program
If anything, this is a reminder that were not in a GLP-1 boom anymore were in a survival market where only truly category-shifting assets deserve to be funded
Introduction In December 2023, Judge Denise Cote barred five expert witnesses from testifying that Johnson & Johnsons Tylenol contributed to the development of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in thousands of children, closing a multi-district litigation [1,2]
GLP-1 agonists are some of the most powerful medicines for weight management that we have to offer, says Raoul Manalac, MD , Senior Director of Clinical Experience for Metabolic Health at Ro
